Solving drug resistance

Avidicure

This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.

Ona Therapeutics

This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.

Abologix

The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Alixia Therapeutics

The company develops therapeutic compounds that disrupt metabolic and inflammatory pathways in the tumor ecosystem for patients with drug-resistant cancer.

tolremo

This company develops small molecule drugs to prevent non-genetic resistance in cancer patients receiving targeted therapies.

ENB Therapeutics

This biopharmaceutical company develops small molecule endothelin B receptor inhibitors to treat drug-resistant cancers for patients undergoing immunotherapy.

Cytospire Therapeutics

This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.